Your browser doesn't support javascript.
loading
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
Allen, Richard J; Guillen-Guio, Beatriz; Oldham, Justin M; Ma, Shwu-Fan; Dressen, Amy; Paynton, Megan L; Kraven, Luke M; Obeidat, Ma'en; Li, Xuan; Ng, Michael; Braybrooke, Rebecca; Molina-Molina, Maria; Hobbs, Brian D; Putman, Rachel K; Sakornsakolpat, Phuwanat; Booth, Helen L; Fahy, William A; Hart, Simon P; Hill, Mike R; Hirani, Nik; Hubbard, Richard B; McAnulty, Robin J; Millar, Ann B; Navaratnam, Vidyia; Oballa, Eunice; Parfrey, Helen; Saini, Gauri; Whyte, Moira K B; Zhang, Yingze; Kaminski, Naftali; Adegunsoye, Ayodeji; Strek, Mary E; Neighbors, Margaret; Sheng, Xuting R; Gudmundsson, Gunnar; Gudnason, Vilmundur; Hatabu, Hiroto; Lederer, David J; Manichaikul, Ani; Newell, John D; O'Connor, George T; Ortega, Victor E; Xu, Hanfei; Fingerlin, Tasha E; Bossé, Yohan; Hao, Ke; Joubert, Philippe; Nickle, David C; Sin, Don D; Timens, Wim.
Afiliação
  • Allen RJ; Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
  • Guillen-Guio B; Unidad de Investigacion, Hospital Universitario Ntra. Sra. de Candelaria and.
  • Oldham JM; Department of Internal Medicine, University of California Davis, Davis, California.
  • Ma SF; Division of Pulmonary and Critical Care Medicine.
  • Dressen A; Genentech, South San Francisco, California.
  • Paynton ML; Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
  • Kraven LM; Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
  • Obeidat M; The University of British Columbia Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Li X; The University of British Columbia Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Ng M; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences.
  • Braybrooke R; Division of Epidemiology and Public Health and.
  • Molina-Molina M; National Institute for Health Research, Nottingham Biomedical Research Centre and.
  • Hobbs BD; Servei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.
  • Putman RK; Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain.
  • Sakornsakolpat P; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
  • Booth HL; Channing Division of Network Medicine.
  • Fahy WA; Division of Pulmonary and Critical Care Medicine.
  • Hart SP; Division of Pulmonary and Critical Care Medicine.
  • Hill MR; Channing Division of Network Medicine.
  • Hirani N; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Hubbard RB; Department of Thoracic Medicine, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • McAnulty RJ; Discovery Medicine, GlaxoSmithKline, Stevenage, United Kingdom.
  • Millar AB; Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom.
  • Navaratnam V; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health.
  • Oballa E; Medical Research Council Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom.
  • Parfrey H; Division of Epidemiology and Public Health and.
  • Saini G; National Institute for Health Research, Nottingham Biomedical Research Centre and.
  • Whyte MKB; UCL Respiratory Centre for Inflammation and Tissue Repair, University College London, London, United Kingdom.
  • Zhang Y; Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.
  • Kaminski N; Division of Epidemiology and Public Health and.
  • Adegunsoye A; National Institute for Health Research, Nottingham Biomedical Research Centre and.
  • Strek ME; Discovery Medicine, GlaxoSmithKline, Stevenage, United Kingdom.
  • Neighbors M; Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital, Cambridge, United Kingdom.
  • Sheng XR; Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Gudmundsson G; Medical Research Council Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom.
  • Gudnason V; Division of Pulmonary, Allergy and Critical Care Medicine and.
  • Hatabu H; Simmons Center for Interstitial Lung Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Lederer DJ; Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Manichaikul A; Section of Pulmonary and Critical Care, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • Newell JD; Section of Pulmonary and Critical Care, Department of Medicine, The University of Chicago, Chicago, Illinois.
  • O'Connor GT; Genentech, South San Francisco, California.
  • Ortega VE; Genentech, South San Francisco, California.
  • Xu H; Department of Respiratory Medicine, Landspital University Hospital, Reykjavik, Iceland.
  • Fingerlin TE; Faculty of Medicine University of Iceland, Reykjavik, Iceland.
  • Bossé Y; Faculty of Medicine University of Iceland, Reykjavik, Iceland.
  • Hao K; Icelandic Heart Association, Kopavogur, Iceland.
  • Joubert P; Department of Radiology, and.
  • Nickle DC; Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Boston, Massachusetts.
  • Sin DD; Department of Medicine, College of Physicians and Surgeons and.
  • Timens W; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Am J Respir Crit Care Med ; 201(5): 564-574, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31710517
ABSTRACT
Rationale Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. Genome-wide association studies have reported signals of association implicating multiple pathways including host defense, telomere maintenance, signaling, and cell-cell adhesion.

Objectives:

To improve our understanding of factors that increase IPF susceptibility by identifying previously unreported genetic associations.

Methods:

We conducted genome-wide analyses across three independent studies and meta-analyzed these results to generate the largest genome-wide association study of IPF to date (2,668 IPF cases and 8,591 controls). We performed replication in two independent studies (1,456 IPF cases and 11,874 controls) and functional analyses (including statistical fine-mapping, investigations into gene expression, and testing for enrichment of IPF susceptibility signals in regulatory regions) to determine putatively causal genes. Polygenic risk scores were used to assess the collective effect of variants not reported as associated with IPF.Measurements and Main

Results:

We identified and replicated three new genome-wide significant (P < 5 × 10-8) signals of association with IPF susceptibility (associated with altered gene expression of KIF15, MAD1L1, and DEPTOR) and confirmed associations at 11 previously reported loci. Polygenic risk score analyses showed that the combined effect of many thousands of as yet unreported IPF susceptibility variants contribute to IPF susceptibility.

Conclusions:

The observation that decreased DEPTOR expression associates with increased susceptibility to IPF supports recent studies demonstrating the importance of mTOR signaling in lung fibrosis. New signals of association implicating KIF15 and MAD1L1 suggest a possible role of mitotic spindle-assembly genes in IPF susceptibility.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido